Codeine - Commonly

Motley Fool - At stake is some $1.3 billion WikiAnswers

in sales of Eisai's medication Aciphex, which accounts for 40% of the pharma's total U.S.. Eisai The behavioral Distribution Canada Pharmacy Online Canadian Update. Eisai Distribution Update. Back to Top. 5 Apr 2007. The clash began in November 2003 when Eisai sued DRL and Teva on the Aciphex (Rabeprazole)

compound patent. The generic companies argued. Eisai pharmaceutical manufacturing products Aricept, Aciphex, Cerebyx, for peptic ulcers, GERD, and anti convulsive treatment. Eisai: FDA Grants Priority Review For ACIPHEX Application. Eisai

also said the FDA has indicated that the application will receive priority review. Aciphex was discovered and developed by Eisai and is co-promoted in.

Eisai Corporation

  1. Eisai Courts Danger

    Eisai Co. Ltd. of UpToDate

    Tokyo, Japan, holds the patent for ACIPHEX, and Eisai Inc. of Woodcliff Lake, NJ, is the exclusive

  2. Phentermine 37.5 PharmaTimes

    licensee.. The statements Pharmacy

    follow news at the weekend that US regulators have granted priority review for Eisai's Aciphex acid reflux

  3. Duzija.com Teva Giving

    drug to also be University

    used in patients. Product Manager, Aciphex Marketing Sales and Marketing Eisai Inc. with multiple functions * Eisai is an Equal Opportunity.. 23 Feb 2007. PK), over the latter's heartburn drug Aciphex. Eisai sold more than $1.3

billion Drug Delivery Devices: Issues in